Newborn Screening Market Size, Share, Growth, Trends, and Global Industry Analysis: By Technology (Electrophoresis, Immunoassays & Enzymatic assays, DNA-based Assays, Hearing Screen Technology, Pulse Oximetry Screening Technology, Tandem Mass Spectrometry (TMS)), By Product Type (Newborn Hearing Screening Instruments, Newborn Disorder Screening Instruments, Hearing Screening Accessories, Hearing Screening Devices, Pulse Oximeters, Reagents and Assay Kits), By Test Type (Dry Blood Spot Test, Hearing Screen Test, Critical Congenital Heart Diseases (CCHD) TEST), By Distribution Channel (Hospitals, Ambulatory Surgical Centers, Nursing Homes), and Region Forecast 2019-2030

Newborn Screening Market size was valued at US$ 838 million in 2023 and is poised to grow at a CAGR of 7.9% from 2024 to 2030. Newborn screening is the practice where every newborn baby is tested for certain potentially fatal disorders. As newborns are more liable to infections, newborn screening helps in early diagnosis and proper treatment which can make the difference between lifelong impairment and healthy development. Newborn screening consists of a bloodstream test, hearing screening, and screening for critical congenital heart defects.

The screening is done within few days of birth. These screening programs are generally run by state or national governing bodies. In this program, various initiatives have been taken by the Japans Society of Obstetrics and Gynecology (JSOG), UK (PEACH), and U.S. Department of Health and Human Services Secretarys Advisory Committee on Heritable Disorders in Newborns and Children (SACHDNC). WHO recommended the newborn screening program in order to safeguard the health of children all over the world.

Newborn screening not only saves lives but can also improve the health of the children. The World Health Organization has stated that over 270,000 babies globally die of congenital disorders. In 2010, the WHO has taken a step in order to resolve the neonatal deaths by developing strong surveillance systems. It is reported that more than 2.8 million babies die within the first month due to improper care and screening of the babies. In order to prevent these deaths WHO, Healthy Newborn Network, etc., has taken efforts to bring awareness by educating the parents about the neonatal disorders and the process of safeguarding the health of children.

Newborn Screening Market Key Developments

• In February 2018, Sema4, a health information company providing advanced genomic testing, announced the launch of Sema4 Natalis, a supplemental newborn screening test designed to detect 193 childhood-onset diseases or disorders so parents can gain insight into their babys health.